DexCom, Inc. Equity-NMS: DXCM

Healthcare

Medical Devices

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$84.1
Open :	$84.7
Today's high :	$84.78
Today's low :	$83.23
52W low :	$57.52
52W high :	$113.28
1Y :	-25.14%
5Y :	-22.05%
EPS(TTM): :	1.33
Shares O/S :	392.11 M
Market cap :	32.89 B

What is the share price of DexCom, Inc. today?

DexCom, Inc. (DXCM) share price as of July 21, 2025, is $83.89. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of DexCom, Inc.?

Yes, Indian Investors can invest in the DexCom, Inc. (DXCM) Share by opening an international trading account with Angel One.

How can I purchase DexCom, Inc. shares in India?

Purchasing DexCom, Inc. (DXCM) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying DexCom, Inc. (DXCM) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of DexCom, Inc.?

Yes, you can purchase fractional shares of DexCom, Inc. (DXCM) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of DexCom, Inc.?

The market capitalization of DexCom, Inc. on July 21, 2025, is $32.89 B.

In which sector DexCom, Inc. belongs?

DexCom, Inc. operates in the Healthcare sector, specifically in the Medical Devices industry.

What documents are required to invest in DexCom, Inc. stocks?

In order to invest in DexCom, Inc. (DXCM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.